Dr Wolfgang Koehler, friend and medical advisor to ALD Life, recently published a paper on treating adults with cerebral ALD with HSCT. The paper provides an update on the latest research and reports outcome improvements of 25%, showing that HSCT may be a suitable treatment option for adult cerebral ALD patients. Dr Koehler concludes: “the success of any transplant heavily depends on certain circumstances … but HSCT [in adults] is a step forward – at least for people with cerebral ALD”: www.ncbi.nlm.nih.gov/pubmed/30132230
ncbi.nlm.nih.gov
J Inherit Metab Dis. 2018 Aug 21. doi: 10.1007/s10545-018-0241-9. [Epub ahead of print]